assessing the workplace environment for antineoplastic exposure
TRANSCRIPT
![Page 1: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/1.jpg)
Assessing the Workplace for Antineoplastic Drug Exposure
Jackie Gambrell, RN, BSN, OCN
Oncology Nurse Navigator
Oncology Multidisciplinary Center
Cancer Treatment Center
Greenville Hospital System University Medical Center
South Carolina Magnet ConferenceApril 28, 2006
![Page 2: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/2.jpg)
Discussion Topics• Drug Exposure in the Workplace
• Regulating Agencies and Drug-Handling Guidelines
• Assessing Work Practice Environments
• Improving Compliance – SOLVE
• Promoting Practice Change
• Questions and Answers
©
![Page 3: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/3.jpg)
Drug Exposure In the Workplace
• Evidence of Exposure Risks
• Factors Affecting Worker Exposure– Drug Handling– Potential for Absorption– Safety Equipment– PPE
• Measuring Policy Compliance
![Page 4: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/4.jpg)
Regulating Agencies Providing Guidelines
OSHA Publication #8-1.1
NIOSH Publication No. 2004-165
Chemotherapy and Biotherapy Guidelines
Guidelines for Handling Hazardous Drugs
![Page 5: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/5.jpg)
Workplace Environment
PatientOutcomes
Compliance Reporting
WorkerSafety
Compliance Training and Awareness
![Page 6: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/6.jpg)
Implementing Workplace Compliance
• Situation Assessment
• Order the Investigation
• Live Evidence Collection
• Verify the Analysis
• Effective Corrective Action
©
![Page 7: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/7.jpg)
(S) Situation Assessment
• Find chronic problems • The cost approach problem selection method• The impact / effort problem selection method
![Page 8: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/8.jpg)
(O) Organize The Investigation
• The formal analysis team
• The informal analysis team
• The individual problem solver
![Page 9: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/9.jpg)
(L) Live Evidence Collection
• (F) Find and interview people• (A) Act quickly to begin the investigation• (C) Collect physical evidence• (T) Track time and position• (S) Search for cause and effect relationships
![Page 10: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/10.jpg)
(V) Verified Analysis
• Problem definition• Problem analysis
• Root cause discovery• Logic tree examples• Site specific practice
![Page 11: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/11.jpg)
(E) Effective Corrective Action
• Actions to eliminate root cause• Management review and approval
• Engineering• Procedures and training• Planning, scheduling and execution• Tracking for success
![Page 12: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/12.jpg)
The Key to SOLVE Success!
•Valued
•Effective
•Fully Integrated into the workplace
TEAMWORK
©
![Page 13: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/13.jpg)
Investigational Model For Assessing Non-Compliance
*Source:
![Page 14: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/14.jpg)
Summary
• Preventing Hazardous Drug Exposure
• Implementing State, Federal and Organizational Guidelines
• Assessing your Organization
• Improving your Workplace Compliance
• Using a Proven Process such as SOLVE©
![Page 15: Assessing the Workplace Environment for Antineoplastic Exposure](https://reader034.vdocuments.mx/reader034/viewer/2022042607/559dfa6c1a28ab4f468b4732/html5/thumbnails/15.jpg)
Questions and Answers
Jackie Gambrell, RN, BSN, OCN
Oncology Nurse Navigator
Oncology Multidisciplinary Center
Cancer Treatment Center
Greenville Hospital System University Medical Center